Works matching DE "ANTINEOPLASTIC agents"

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Activation of a nongenetic AHR-ELMSAN1 axis optimizes BET-targeting therapy and suppresses leukemia stem cells in preclinical models.

    Published in:
    Science Translational Medicine, 2025, v. 17, n. 810, p. 1, doi. 10.1126/scitranslmed.adn5400
    By:
    • Zhou, Xinyue;
    • Moreira, Steven;
    • Restelli, Cecilia;
    • Wang, Hong;
    • Jahangiri, Soheil;
    • Aryal, Sajesan;
    • Tsao, Emily;
    • Zhang, Pengcheng;
    • Niu, Mingming;
    • Kumar, Harish;
    • Balde, Zaldy;
    • Vujovic, Ana;
    • Liu, Lina;
    • Wong, Nicholas;
    • Arruda, Andrea;
    • Minden, Mark D.;
    • Zhou, Yang;
    • Ravi, Bhatia;
    • Qi, Jun;
    • Li, Chunliang
    Publication type:
    Article
    15

    Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02089-4
    By:
    • López-Miranda, Elena;
    • Pérez-García, Jose Manuel;
    • Gión, María;
    • Ribelles, Nuria;
    • Cortez-Castedo, Patricia;
    • Alonso-Romero, José Luis;
    • García, María Martínez;
    • González-Santiago, Santiago;
    • Bermejo, Begoña;
    • Morales, Serafín;
    • Carañana, Vicente;
    • Garrigós, Laia;
    • Fernández-Pinto, Melissa;
    • García-Vicente, Silvia;
    • Garcia-Sanz, Alicia;
    • Mena-Molina, Arnau;
    • Boix, Olga;
    • Alcalá-López, Daniel;
    • Llombart-Cussac, Antonio;
    • Cortés, Javier
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER).

    Published in:
    Oncologist, 2025, v. 30, n. 7, p. 1, doi. 10.1093/oncolo/oyaf200
    By:
    • Angelis, Carmine De;
    • Pagliuca, Martina;
    • Magnolfi, Emanuela;
    • Mansutti, Mauro;
    • Ballatore, Zelmira;
    • Laurentiis, Michelino De;
    • Bordonaro, Roberto;
    • Leonardi, Vita;
    • Bruzzese, Dario;
    • Caputo, Roberta;
    • Mosconi, Anna Maria;
    • Cinieri, Saverio;
    • Fabi, Alessandra;
    • Mastro, Lucia Del;
    • Puglisi, Fabio;
    • Placido, Sabino De;
    • Giuliano, Mario;
    • Arpino, Grazia
    Publication type:
    Article
    32
    33
    34
    35
    36

    Cartoon: multicenter prospective observational study of Cardiovascular Toxicity of Trifluridine/Tipiracil in metastatic colorectal cancer.

    Published in:
    Oncologist, 2025, v. 30, n. 7, p. 1, doi. 10.1093/oncolo/oyaf178
    By:
    • Leone, Francesco;
    • Fiamma, Valeria;
    • Crivelli, Francesca;
    • Paris, Myriam Katja;
    • Forti, Laura Giovanna;
    • Brizzi, Maria Pia;
    • Sperti, Elisa;
    • Laface, Rosa;
    • Tober, Nastassja;
    • Salerno, Flavio;
    • Traverso, Elena Silvia;
    • Parlagreco, Elena;
    • Nepote, Alessandro;
    • Giuli, Angelo;
    • Bonessio, Elisa;
    • Nicolì, Elena;
    • Bertola, Benedetta;
    • Montagnani, Francesco
    Publication type:
    Article
    37
    38
    39
    40
    41
    42

    Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study.

    Published in:
    Oncologist, 2025, v. 30, n. 7, p. 1, doi. 10.1093/oncolo/oyae330
    By:
    • Valenza, Carmine;
    • Nicolò, Eleonora;
    • Mongillo, Marta;
    • Trapani, Dario;
    • Katrini, Jalissa;
    • Boldrini, Laura;
    • Bielo, Luca Boscolo;
    • Castellano, Grazia;
    • Guidi, Lorenzo;
    • Pellizzari, Gloria;
    • Villa, Jacopo;
    • Derio, Silvia;
    • Lapresa, Mariateresa;
    • Gigli, Federica;
    • Parma, Gabriella;
    • Salè, Emanuela Omodeo;
    • Derenzini, Enrico;
    • Curigliano, Giuseppe;
    • Colombo, Nicoletta
    Publication type:
    Article
    43

    Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25.

    Published in:
    Oncologist, 2025, v. 30, n. 7, p. 1, doi. 10.1093/oncolo/oyae322
    By:
    • Montégut, Coline;
    • Falandry, Claire;
    • Cinieri, Saverio;
    • Cropet, Claire;
    • Montane, Laure;
    • Rousseau, Frédérique;
    • Joly, Florence;
    • Moubarak, Malak;
    • Mosconi, Anna M;
    • Guerra-Alía, Eva M;
    • Schauer, Christian;
    • Fujiwara, Hiroyuki;
    • Vergote, Ignace;
    • Parma, Gabriella;
    • Lindahl, Gabriel;
    • Anota, Amélie;
    • Canzler, Ulrich;
    • Marmé, Frederik;
    • Pujade-Lauraine, Eric;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50